LLY · 10-Q · 2026Q2 · Full report
Liquidity and Cash Position
ELI LILLY & Co · 2026-08-05 · Importance 46 · Surprise 30 · From source text
Cash and cash equivalents increased to $9.0 billion at June 30, 2026 from $7.3 billion at December 31, 2025. Total investments rose to $3.9 billion from $2.9 billion over the same period. Lilly had approximately $806 million of unfunded venture-capital commitments expected to be paid over up to 10 years. The company reported $10.1 billion of unused committed bank credit facilities, including $10.0 billion available to support commercial paper.
Key facts
- As of June 30, 2026, the Company had $10.1 billion of unused committed bank credit facilities, $10.0 billion of which is available to support the commercial paper program. source
- Cash and cash equivalents increased to $9.0 billion as of June 30, 2026, compared with $7.3 billion as of December 31, 2025. source
- Total investments held as of June 30, 2026: $3.9 billion; as of December 31, 2025: $2.9 billion. source
- Approximately $806 million of unfunded commitments to invest in venture capital funds as of June 30, 2026, anticipated to be paid over up to 10 years. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | realized | +1.2% | Cash and cash equivalents increased to $9.0 billion as of June 30, 2026, compared with $7.3 billion as of December 31, 2025. |
| assets | positive | realized | +0.7% | Total investments held as of June 30, 2026: $3.9 billion; as of December 31, 2025: $2.9 billion. |
| liability | negative | committed | -0.5% | Approximately $806 million of unfunded commitments to invest in venture capital funds as of June 30, 2026, anticipated to be paid over up… |